Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study

Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study

Abstract Background The impact of corticosteroids on patients with severe coronavirus disease 2019 (COVID-19)/chronic hepatitis B virus (HBV) co-infection is currently unknown. We aimed to investigate the association of corticosteroids on these patients. Methods This retrospective multicenter study...

Full description

Bibliographic Details
Main Authors: Mei Meng, Yufeng Chu, Sheng Zhang, Xuechuan Li, Jing Sha, Peng Wang, Yunliang Cui, Meihong Han, Xuan Dong, Wenqing Sun, Zhongfa Zhang, Yunxin Deng, Tao Wang, Djillali Annane, Shouqiang Jia, Dechang Chen
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
HBV
Co-infection
Corticosteroid treatment
Online Access:https://doi.org/10.1186/s12879-022-07882-6

Internet

https://doi.org/10.1186/s12879-022-07882-6

Similar Items